Tavaborole Solution
NDC Package 21922-020-12

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Tavaborole (tavaborole topical solution, 5%) solution is a medication used to treat toenail infection caused by fungus. This formulation utilizes a solution delivery system. Marketed by Encube Ethicals, Inc., this product is identified by NDC 21922-020 and is authorized under FDA application ANDA211297.

Identification & Billing

NDC Package Code
21922-020-12
Package Description
1 BOTTLE, WITH APPLICATOR in 1 CARTON / 10 mL in 1 BOTTLE, WITH APPLICATOR
Product Code
21922-020
11-Digit Billing Format
21922002012
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Tavaborole
Non-Proprietary Name
Tavaborole Topical Solution, 5%
Substance Name
Tavaborole
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
TAVABOROLE 43.5 mg/mL
Pharmacologic Class
Usage Information
This medication is used to treat toenail infection caused by fungus. It works by stopping the growth of certain types of fungus. Tavaborole belongs to a class of drugs known as oxaborole antifungals. This medication treats only fungal infections. It will not work for other types of infection, such as those caused by bacteria. Unnecessary use or misuse of any drug used to treat infection can lead to its decreased effectiveness.

Regulatory & Marketing

Labeler Name
Encube Ethicals, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA211297
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-19-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 21922-020-12 identifies a specific commercial package of 1 bottle, with applicator in 1 carton / 10 ml in 1 bottle, with applicator of Tavaborole, a human prescription drug labeled by Encube Ethicals, Inc.. This solution is formulated for topical use and contains tavaborole as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Encube Ethicals, Inc. on October 19, 2020. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat toenail infection caused by fungus. It works by stopping the growth of certain types of fungus. Tavaborole belongs to a class of drugs known as oxaborole antifungals. This medication treats only fungal infections. It will not work for other types of infection, such as those caused by bacteria. Unnecessary use or misuse of any drug used to treat infection can lead to its decreased effectiveness.

How is this Encube Ethicals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 21922002012. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
21922-020-12
11-Digit CMS (5-4-2)
21922-0020-12

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.